Targeting the gut-retina axis: mechanistic insights and therapeutic prospects for diabetic retinopathy
Inflammopharmacology · 2025-12 · 33 (12) · 7329-7345
DOI: 10.1007/s10787-025-02022-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, online erschienen am 10.11.2025. Verfasst von Yang Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Gastrointestinal Microbiome, Retina. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 119 Literaturangaben. Gefördert von: The National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China. liaoyanbucm@163.com.
Förderung
- The National Natural Science Foundation of China
Zitieren
APA
Jiang, Y., Tang, Y., Liu, Z., Yang, X., Zhou, M., Liang, Y., Ding, J., & Liao, Y. (2025). Targeting the gut-retina axis: mechanistic insights and therapeutic prospects for diabetic retinopathy. Inflammopharmacology, 33(12), 7329-7345. https://doi.org/10.1007/s10787-025-02022-3
Vancouver
Jiang Y, Tang Y, Liu Z, Yang X, Zhou M, Liang Y, et al. Targeting the gut-retina axis: mechanistic insights and therapeutic prospects for diabetic retinopathy. Inflammopharmacology. 2025;33(12):7329-7345. doi:10.1007/s10787-025-02022-3
BibTeX
@article{Jiang2025,
author = {Jiang, Yang and Tang, Yibo and Liu, Zhenquan and Yang, Xiangzhu and Zhou, Manyu and Liang, Yao and Ding, Jiazhen and Liao, Yan},
title = {Targeting the gut-retina axis: mechanistic insights and therapeutic prospects for diabetic retinopathy},
journal = {Inflammopharmacology},
year = {2025},
volume = {33},
number = {12},
pages = {7329--7345},
doi = {10.1007/s10787-025-02022-3}
}
EUVIMED